To treat or not to treat: metabolomics reveals biomarkers for treatment indication in chronic lymphocytic leukaemia patients

In chronic lymphocytic leukaemia (CLL), the clinical course of patients is heterogeneous. Some present an aggressive disease onset and require immediate therapy, while others remain without treatment for years. Current disease staging systems developed by Rai and Binet may be useful in forecasting p...

Full description

Saved in:
Bibliographic Details
Published in:Oncotarget
Main Authors: Piszcz, Jaroslaw, Armitage, Emily G., Ferrarini, Alessia, Rupérez, Francisco J., Kulczynska, Agnieszka, Bolkun, Lukasz, Kloczko, Janusz, Kretowski, Adam, Urbanowicz, Alina, Ciborowski, Michal, Barbas, Coral
Format: Artigo
Language:Inglês
Published: Impact Journals LLC 2016
Subjects:
Research Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5008363/
https://ncbi.nlm.nih.gov/pubmed/26988915
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8078
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items